Michael Greger Quotes

No matter how counter-intuitive it may seem, basic research has proven over and over to be the lifeline of practical advances in medicine.

There are so many things that go into a surgical study.

Medical research in the twentieth century mostly takes place in the lab; in the Renaissance, though, researchers went first and foremost to the library to see what the ancients had said.

I'm involved in Project ALS which is trying to get money for stem cell research. That's one I've been pretty involved with because if you can cure that, you can cure so many other diseases.

If you put me in charge of the medical research budget, I would cancel all primary research, I would cancel all new trials, for just one year, and I would spend the money exclusively on making sure that we make the best possible use of the clinical evidence that we already have.

We must continue to fight for funding for health technologies so that they can continue to do what they do best - save lives - but also because they confer a real benefit to America's economy.

Dedicated researchers seek better treatments and cures for diabetes, kidney disease, Alzheimer's and every form of cancer. But these scientists face an array of disincentives. We can do better.

I have an obligation to use what I know to try to bring real, usable medical science to every doctor and bedside and patient.

Alzheimer's is literally killing us, and the only way to fight this 'crime' is through a groundswell of people who continue to raise their voices and funds to ensure it gets the attention it deserves.

I started this foundation when I was diagnosed. It was established for one reason, and that was to try to find a cure for MS. Every penny, 100% of the public donations that come into this are given back out in the form of grants to colleges and researchers around the world.

As soon as we find a cure, we will utilize any of the donations to go toward providing medication to those who can't afford it. That is my goal.

In the collecting of evidence upon any medical subject, there are but three sources from which we can hope to obtain it: viz. from observation of the living subject; from examination of the dead; and from experiments upon living animals.

We now have the ability to explore many new treatments for many diseases. However we do not have enough money to explore them all…. I measure time by the number of patients who die each day as the result of diseases that we do not have enough money to develop cures for. We have the tools. We need the money.

The business of biomedical research is mostly about failure. Few projects we commission will ultimately result in success. But every study we do contributes to the body of knowledge that brings science and society closer to a solution.

In order for America to remain the leader in medical innovation, we must reduce costs, ease regulatory burdens, and increase the efficacy of producing new treatments and cures here in the U.S.

Affordability is critical so that patients have access to medicines. At the same time, it's also important that we have the kind of incentives that allow us to do the kinds of studies that we need to do to go after these diseases like Alzheimer's.

Traditionally, when you talk to people who have Parkinson's or Alzheimer's, they'll talk about how they're in five or six studies, and they've been sequenced by each study. That's just fat in the system. Just have a single data set that then you can share. You can make the entire system more efficient.

To ensure that America remains the leader in medical innovation, we must reduce the costs of developing life-saving drugs and ensure that there are appropriate economic incentives in place to produce them.

Research must be central to healthcare if healthcare is to improve.

While I am prepared to look at all options and to think 'outside the box' for effective treatments, I rightly resisted efforts to provide an unproven drug on demand to the American public.

If we can validate our scientific bets in the clinic, if we can bring valuable new treatments to patients that need them, that will be our ultimate measure of success.

Raising money for research and for those suffering with cancer who can't afford treatment is very important to me.

We cannot decide on the efficacy of a medical treatment by counting the number of 'Likes' an intervention receives on Facebook; no matter what, professionals will still need to conduct continued clinical trials and evaluate their outcomes carefully.

I look upon statistics as the handmaid of medicine, but on that very account I hold that it befits medicine to treat her handmaid with proper respect, and not to prostitute her services for controversial or personal purposes.

If a healing technique is demonstrated to have curative properties in properly controlled double-blind trials, it ceases to be alternative. It simply, as Diamond explains, becomes medicine.